CA1341641C - Expression d'un antigene de surface recombinant du vhb - Google Patents

Expression d'un antigene de surface recombinant du vhb

Info

Publication number
CA1341641C
CA1341641C CA375917A CA375917A CA1341641C CA 1341641 C CA1341641 C CA 1341641C CA 375917 A CA375917 A CA 375917A CA 375917 A CA375917 A CA 375917A CA 1341641 C CA1341641 C CA 1341641C
Authority
CA
Canada
Prior art keywords
particles
dna
hepatitis
virus
hbsag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA375917A
Other languages
English (en)
Inventor
Pierre Tiollais
Charles Chany
Marie-Francoise Dubois
Christine Pourcel
Anne Louise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8009041A external-priority patent/FR2480780B1/fr
Priority claimed from FR808026132A external-priority patent/FR2495636B2/fr
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Priority to CA375917A priority Critical patent/CA1341641C/fr
Application granted granted Critical
Publication of CA1341641C publication Critical patent/CA1341641C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA375917A 1980-04-22 1981-04-22 Expression d'un antigene de surface recombinant du vhb Active CA1341641C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA375917A CA1341641C (fr) 1980-04-22 1981-04-22 Expression d'un antigene de surface recombinant du vhb

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR8009041 1980-04-22
FR8009041A FR2480780B1 (fr) 1980-04-22 1980-04-22 Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
FR8026132 1980-12-09
FR808026132A FR2495636B2 (fr) 1980-12-09 1980-12-09 Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
CA375917A CA1341641C (fr) 1980-04-22 1981-04-22 Expression d'un antigene de surface recombinant du vhb

Publications (1)

Publication Number Publication Date
CA1341641C true CA1341641C (fr) 2023-01-17

Family

ID=84952065

Family Applications (1)

Application Number Title Priority Date Filing Date
CA375917A Active CA1341641C (fr) 1980-04-22 1981-04-22 Expression d'un antigene de surface recombinant du vhb

Country Status (1)

Country Link
CA (1) CA1341641C (fr)

Similar Documents

Publication Publication Date Title
US5314808A (en) Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
EP0101617B1 (fr) ADN recombinant contenant un gène du virus de l'hépatite B, cellules mammifères transformées avec l'ADN viral cloné et production de protéines du virus de l'hépatite B
US5310668A (en) Varicella-zoster virus as a live recombinant vaccine
Liao et al. Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs
Roossinck et al. Expression of hepatitis B viral core region in mammalian cells
Seeger et al. The cloned genome of ground squirrel hepatitis virus is infectious in the animal.
JP2610015B2 (ja) アデノウイルスプロモーターの制御下で所定のポリペプチドをコードしているヌクレオチド配列を含む組換えｄｎａ
JP2726641B2 (ja) 形質転換脊椎動物細胞の製造方法およびその細胞
Mueller et al. Mapping of early SV40-specific functions by microinjection of different early viral DNA fragments
GB2034323A (en) Production of DNA Comprising B Hepatitis Viral Genome
US4442205A (en) Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
JPH0314840B2 (fr)
EP0182442B1 (fr) Molécules de l'ADN recombinant et procédé pour leur production
GB2102006A (en) Deoxyribonucleic acids, their production and use
Jenson et al. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA
EP0062574A2 (fr) Synthèse de protéines de virus
EP0105141A2 (fr) Molécules D'ADN recombinantes, procédé pour leur préparation, leur utilisation dans la production de l'antigène de surface de l'hépatite B (HBsAg) et compositions pharmaceutiques contenant cet HBsAg
Polvino-Bodnar et al. Construction and characterization of viable deletion mutants of simian virus 40 lacking sequences near the 3′ end of the early region
CA1341641C (fr) Expression d'un antigene de surface recombinant du vhb
US6426216B1 (en) Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter
KR960008674B1 (ko) 베리셀라-죠스터 바이러스, 이의 생산방법 및 이를 함유하는 백신
WO1990002176A1 (fr) Hepadnavirus defectif, lignee cellulaire productrice de vaccins et traitement de maladies et de troubles hepatiques
Piccini et al. The use of vaccinia virus for the construction of recombinant vaccines
Denniston et al. Expression of hepatitis B virus surface and e antigen genes cloned in bovine papillomavirus vectors
US6096879A (en) Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby